Pathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies. An estimated 8-12 million people are afflicted by PAD in the United States, and is projected to grow to over 20 million people during the next 10 years. The company's Pathway PV™ Atherectomy System* allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing both hard and soft diseased tissue.

_{*The Pathway PV™ Atherectomy System is not yet approved for sale and is subject to FDA 510(k) clearance.}